Close Menu

NEW YORK (GenomeWeb) – UK-based Angle aims to enter the noninvasive prenatal testing (NIPT) market with its Parsortix cell-based enrichment system. The company recently released results from a pilot study demonstrating the enrichment of circulating fetal cells.

Researchers in the prenatal testing space have been attempting to extract fetal cells from a pregnant woman's bloodstream for decades, with mixed results, and all current providers of NIPT rely on cell-free DNA rather than fetal cells.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

The US Department of Agriculture presents a new blueprint for animal genomic research.

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.